Table 4.
No | Biological activities | Glycycoumarin | Inophyllum P | Mesuol | Oxypeucedanin hydrate | ||||
---|---|---|---|---|---|---|---|---|---|
Pa | Pi | Pa | Pi | Pa | Pi | Pa | Pi | ||
1 | Membrane integrity agonist | 0.937 | 0.002 | – | – | 0.683 | 0.058 | 0.720 | 0.051 |
2 | HMOX1 expression enhancer | 0.635 | 0.015 | – | – | 0.265 | 0.115 | 0.355 | 0.072 |
3 | Chlordeconereductase inhibitor | 0.803 | 0.02 | – | – | 0.243 | 0.193 | 0.344 | 0.132 |
4 | HIF1A expression inhibitor | 0.936 | 0.004 | 0.867 | 0.008 | 0.348 | 0.135 | 0.512 | 0.053 |
5 | Histidine kinase inhibitor | 0.709 | 0.008 | 0.765 | 0.005 | 0.467 | 0.035 | 0.498 | 0.029 |
6 | Aldehyde oxidase inhibitor | 0.807 | 0.009 | – | – | – | – | 0.654 | 0.023 |
7 | Antimutagenic | 0.877 | 0.003 | – | – | – | – | 0.735 | 0.005 |
8 | Mucomembranous protector | 0.648 | 0.081 | – | – | 0.307 | 0.234 | – | – |
9 | TP53 expression enhancer | 0.901 | 0.005 | 0.484 | 0.098 | 0.616 | 0.045 | 0.580 | 0.056 |
10 | Chemopreventive | 0.807 | 0.004 | 0.665 | 0.008 | 0.615 | 0.009 | 0.596 | 0.010 |
Pa: prediction of activity spectra for substances; Pi: probable inactivity